.OS Therapies will definitely list on the NYSE American supply substitution today via a $6.4 million...
.ALX Oncology's phase 2 gastric cancer reaction fee has actually weakened. After viewing its own CD4...
.An Additional of Ionis Pharmaceuticals' vital midphase readouts has fallen short of desires, motiva...
.While Biogen's pharma peers are searching for late-stage possessions with little risk, CEO Chris Vi...
.Instil Biography has actually been a biotech in search of a pipeline after it scrapped its own lead...
.Biogen has returned legal rights to an early Alzheimer's illness plan to Denali Rehabs, going out o...
.Invite to recently's Chutes & Ladders, our summary of considerable management hirings, firings a...
.Vertex's effort to deal with a rare hereditary illness has actually struck one more misfortune. The...
.Vir Biotechnology's second-quarter earnings report had not been short of significant headlines. The...
.Galapagos has actually stopped application in a trial of a BCMA-directed CAR-T cell treatment, push...